Shanghai-based Bioheart is a leading interventional cardiovascular device company, listed shares in December on the Hong Kong stock exchange. It issued a total of 23.937 million shares in a global…
Shanghai-based Bioheart is a leading interventional cardiovascular device company, listed shares in December on the Hong Kong stock exchange. It issued a total of 23.937 million shares in a global…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference